Informations générales (source: ClinicalTrials.gov)
STEpwise Research Program to Promote INGeniouS ONline Supportive Solutions in the Relief of Cancer-related Fatigue (STEPPING-STONe)
Interventional
N/A
Gustave Roussy, Cancer Campus, Grand Paris (Voir sur ClinicalTrials)
septembre 2025
novembre 2027
02 octobre 2025
Decentralized, randomized hybrid type 2 (effectiveness/implementation) controlled trial
comparing the effectiveness of three different digital aid modalities programs in
reducing the perceived burden of CRF in cancer patients while also gathering data on the
implementation strategy.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT GUSTAVE ROUSSY | In�s Maria VAZ DUARTE LUIS | 21/04/2026 16:25:05 | Contacter | ||
Critères
Tous
- Age 18 years and older.
- Having a clinical diagnosis of cancer including patients on active treatment or
cancer survivors.
- Self-reporting moderate to severe CRF for at least one week (worst level of fatigue
≥ 4 on a 10-point numerical rating scale, retained in international guidelines as an
optimal cutoff for identifying clinically significant CRF).
- Being able to read and understand French.
- Having access to a smartphone.
- Patients must be affiliated to a social security system or beneficiary of the same.
Exclusion Criteria:
- Suffering from current psychiatric disorder or cognitive disorder that would
interfere with the ability to consent or participate.
- Currently engaging in cognitive-behavioral therapy.
- Currently engaging in another non-drug (behavioral) clinical trial.
- Suffering from physical related reversible and treatable causes of fatigue (anemia,
electrolytes unbalance, infections, renal dysfunction, active metastases causing
fatigue, hormonal unbalances (hypothyroidism, adrenal insufficiency, etc.) -
according to physician's judgement at the moment of inclusion.